Publicaciones en colaboración con investigadoras/es de Hospital Clínico San Carlos de Madrid (18)

2023

  1. Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review

    Journal of Clinical Medicine, Vol. 12, Núm. 21

2021

  1. Accelerated immunosenescence, oxidation and inflammation lead to a higher biological age in COPD patients

    Experimental Gerontology, Vol. 154

2020

  1. GEHEP 010 study: Prevalence and distribution of hepatitis B virus genotypes in Spain (2000–2016)

    Journal of Infection, Vol. 81, Núm. 4, pp. 600-606

2018

  1. Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among gram-negative organisms recovered during the SMART study in Spain (2011-2015)

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 2, pp. 136-145

2017

  1. Etestw versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: Results from PREMIUM, a European multicentre study

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 2, pp. 431-436

2015

  1. Multicenter Study of Epidemiological Cutoff Values and Detection of Resistance in Candida spp. to Anidulafungin, Caspofungin, and Micafungin Using the Sensititre YeastOne Colorimetric Method

    Antimicrobial Agents and Chemotherapy, Vol. 59, Núm. 11, pp. 6725-6732

2012

  1. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1181-1187

  2. The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?

    Clinical Microbiology and Infection, Vol. 18, Núm. 7

2011

  1. Antimicrobial susceptibility of gram-negative organisms from intra abdominal infections and evolution of isolates with extended spectrum β-lactamases in the smart study in spain (2002-2010)

    Revista Espanola de Quimioterapia, Vol. 24, Núm. 4, pp. 223-232

  2. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 12, pp. 5590-5596

  3. Recomendaciones de vacunación para adultos mayores de 60 años

    Vacunas, Vol. 12, Núm. 2, pp. 56-67

2010

  1. Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain

    Journal of Clinical Microbiology, Vol. 48, Núm. 11, pp. 4200-4206

2008

  1. Neutrophils of centenarians show function levels similar to those of young adults

    Journal of the American Geriatrics Society, Vol. 56, Núm. 12, pp. 2244-2251

  2. Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277

2007

  1. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229

2006

  1. Patrones de sensibilidad a antimicrobianos de Enterobacteriaceae causantes de infecciones intraabdominales en España: Resultados del estudio SMART 2003

    Revista Espanola de Quimioterapia, Vol. 19, Núm. 1, pp. 51-59

2005

  1. Sensibilidad in vitro a los antibióticos y serotipos más frecuentes de Streptococcus pneumoniae. Estudio multicéntrico

    Revista Espanola de Quimioterapia, Vol. 18, Núm. 1, pp. 45-51

2002

  1. In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 3, pp. 892-895